The construction of diabetes dataset was explained. The data were collected from the Iraqi society, as they data were acquired from the laboratory of Medical City Hospital and (the Specializes Center for Endocrinology and Diabetes-Al-Kindy Teaching Hospital). Patients' files were taken and data extracted from them and entered in to the database to construct the diabetes dataset. The data consist of medical information, laboratory analysis. The data attribute are: The data consist of medical information, laboratory analysis… etc. The data that have been entered initially into the system are: No. of Patient, Sugar Level Blood, Age, Gender, Creatinine ratio(Cr), Body Mass Index (BMI), Urea, Cholesterol (Chol), Fasting lipid profile, including total, LDL, VLDL, Triglycerides(TG) and HDL Cholesterol , HBA1C, Class (the patient's diabetes disease class may be Diabetic, Non-Diabetic, or Predict-Diabetic).

These datasets provide de-identified insurance data for diabetes. The data is provided by three managed care organizations in Allegheny County (Gateway Health Plan, Highmark Health, and UPMC) and represents their insured population for the 2015 and calendar years.

Disclaimer: Users should be cautious of using administrative claims data as a measure of disease prevalence and interpreting trends over time, as data provided were collected for purposes other than surveillance. Limitations of these data include but are not limited to: misclassification, duplicate individuals, exclusion of individuals who did not seek care in past two years and those who are: uninsured, enrolled in plans not represented in the dataset, or were not enrolled in one of the represented plans for at least 90 days.

Support for Health Equity datasets and tools provided by Amazon Web Services (AWS) through their Health Equity Initiative.

This data set provides de-identified population data for diabetes and hypertension comorbidity prevalence in Allegheny County. The data is provided by three managed care organizations in Allegheny County (Gateway Health Plan, Highmark Health, and UPMC) and represents their insured population for the 2015 and 2016 calendar years.

Disclaimer: Users should be cautious of using administrative claims data as a measure of disease prevalence and interpreting trends over time, as data provided were collected for purposes other than surveillance. Limitations of these data include but are not limited to: misclassification, duplicate individuals, exclusion of individuals who did not seek care in past two years and those who are: uninsured, enrolled in plans not represented in the dataset, or were not enrolled in one of the represented plans for at least 90 days.

Support for Health Equity datasets and tools provided by Amazon Web Services (AWS) through their Health Equity Initiative.

Germany. There are eight features in the dataset. Among the 2000 samples

Population-based county-level estimates for prevalence of DC were obtained from the Institute for Health Metrics and Evaluation (IHME) for the years 2004-2012 (16). DC prevalence rate was defined as the propor-tion of people within a county who had previously been diagnosed with diabetes (high fasting plasma glu-cose 126 mg/dL, hemoglobin A1c (HbA1c) of 6.5%, or diabetes diagnosis) but do not currently have high fasting plasma glucose or HbA1c for the period 2004-2012. DC prevalence estimates were calculated using a two-stage approach. The first stage used National Health and Nutrition Examination Survey (NHANES) data to predict high fasting plasma glucose (FPG) levels (≥126 mg/dL) and/or HbA1C levels (≥6.5% [48 mmol/mol]) based on self-reported demographic and behavioral characteristics (16). This model was then applied to Behavioral Risk Factor Surveillance System (BRFSS) data to impute high FPG and/or HbA1C status for each BRFSS respondent (16). The second stage used the imputed BRFSS data to fit a series of small area models, which were used to predict county-level prevalence of diabetes-related outcomes, including DC (16). The EQI was constructed for 2006-2010 for all US counties and is composed of five domains (air, water, built, land, and sociodemographic), each composed of variables to represent the environmental quality of that _domain. Domain-specific EQIs were developed using principal components analysis (PCA) to reduce these variables within each _domain while the overall EQI was constructed from a second PCA from these individual domains (L. C. Messer et al., 2014). To account for differences in environment across rural and urban counties, the overall and _domain-specific EQIs were stratified by rural urban continuum codes (RUCCs) (U.S. Department of Agriculture, 2015). Results are reported as prevalence rate differences (PRD) with 95% confidence intervals (CIs) comparing the highest quintile/worst environmental quality to the lowest quintile/best environmental quality expo-sure metrics. PRDs are representative of the entire period of interest, 2004-2012. Due to availability of DC data and covariate data, not all counties were captured, however, the majority, 3134 of 3142 were utilized in the analysis. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Human health data are not available publicly. EQI data are available at: https://edg.epa.gov/data/Public/ORD/NHEERL/EQI. Format: Data are stored as csv files. This dataset is associated with the following publication: Jagai, J., A. Krajewski, K. Price, D. Lobdell, and R. Sargis. Diabetes control is associated with environmental quality in the USA. Endocrine Connections. BioScientifica Ltd., Bristol, UK, 10(9): 1018-1026, (2021).

Using CERNER records of pregnancies monitored at St. Mary's Hospital in London from April 2016 to November 2019, we carried out a retrospective observational research. 26063 patients were found in the initial search results, with the following factors: Postcode, height, weight, BMI at booking, ethnicity (self-reported), parity, offer of a glucose tolerance test, results of the test (0 minutes and 120 minutes after a 75g glucose load), mode of delivery, estimated total blood loss, gestational age, neonatal birthweight, admission to a SCBU, length of stay after delivery, foetal sex, and stillbirth are some of the other factors taken into account. Prior to analysis, patients having missing values for one or more of the important variables were deleted from the dataset. We did not make an effort to impute missing data. When reexamining the original patient data was not possible, significantly outlying results were adjusted, and datasets were then eliminated. Unit measurement inconsistencies were fixed.

Overview

We are trying to build a machine learning model to accurately predict whether the patients have diabetes or not.our objective is to prevent, cure and to improve the lives of all people affected by diabetes.

Details about the Dataset

The datasets consists of several medical predictor variables and one target variable, Outcome. Predictor vari- ables includes the number of pregnancies the patient has had, their BMI, insulin level, age, and so on.

Pregnancies: Number of times pregnant Glucose: Plasma glucose concentration a 2 hours in an oral glucose tolerance test BloodPressure: Diastolic blood pressure (mm Hg) SkinThickness: Triceps skin fold thickness (mm) Insulin: 2-Hour serum insulin (mu U/ml) BMI: Body mass index (weight in kg/(height in m)2) DiabetesPedigreeFunction: Diabetes pedigree function Age:Age(years) Outcome: Classvariable(0 or 1)

Motivation

The motivation was to experiment with end to end machine learning project and get some idea about deployment platform like and offcourse this " Diabetes is an increasingly growing health issue due to our inactive lifestyle. If it is detected in time then through proper medical treatment, adverse effects can be prevented. To help in early detection, technology can be used very reliably and efficiently. Using machine learning we have built a predictive model that can predict whether the patient is diabetes positive or not.". This is also sort of fun to work on a project like this which could be beneficial for the society.

This dataset presents information on age-sex specific incidence rates of diabetes by First Nations status for Alberta, expressed as per 100,000 population.

This table contains 267456 series, with data for years 2000 - 2000 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (199 items: Canada; Newfoundland and Labrador; Health and Community Services St. John's Region; Newfoundland and Labrador (Peer group H); Health and Community Services Eastern Region; Newfoundland and Labrador (Peer group D) ...), Age group (14 items: Total; 12 years and over; 12-19 years; 12-14 years; 15-19 years ...), Sex (3 items: Both sexes; Males; Females ...), Diabetes (4 items: Total population for the variable diabetes; Without diabetes; Diabetes; not stated; With diabetes ...), Characteristics (8 items: Number of persons; High 95% confidence interval - number of persons; Coefficient of variation for number of persons; Low 95% confidence interval - number of persons ...).

United States US: Diabetes Prevalence: % of Population Aged 20-79 data was reported at 10.790 % in 2017. United States US: Diabetes Prevalence: % of Population Aged 20-79 data is updated yearly, averaging 10.790 % from Dec 2017 (Median) to 2017, with 1 observations. United States US: Diabetes Prevalence: % of Population Aged 20-79 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes.; ; International Diabetes Federation, Diabetes Atlas.; Weighted average;

This dataset provides a collection of Continuous Glucose Monitoring (CGM) data, insulin dose administration, meal ingestion counted in carbohydrate grams, steps, calories burned, heart rate, and sleep quality and quantity assessment acquired from 25 people with type 1 diabetes mellitus (T1DM). CGM data was acquired by FreeStyle Libre 2 CGMs, and Fitbit Ionic smartwatches were used to obtain steps, calories, heart rate, and sleep data for at least 14 days. This dataset could be utilized to obtain glucose prediction models, hypoglycemia and hyperglycemia prediction models, and research on the relationships among sleep, CGM values, and the rest of the mentioned variables. This dataset could be used directly from the preprocessed version or customized from raw data.

This dataset is designed to support researchers, data scientists, and healthcare professionals in predicting and analyzing diabetes prevalence and risk factors among the Indian population. It incorporates a diverse range of demographic, lifestyle, and clinical attributes to ensure a holistic representation of potential diabetes determinants. The dataset's features include:

Demographics: Age, gender, urban/rural residence, and pregnancies (specific to women). Lifestyle Factors: Physical activity, diet type, smoking status, alcohol intake, and stress levels. Medical History: Family history of diabetes, hypertension, thyroid conditions, and regular checkups. Clinical Metrics: BMI, cholesterol levels, fasting and postprandial blood sugar, HBA1C, vitamin D levels, and more. Target Variable: Binary diabetes status (Yes/No).

This dataset presents information on age-standardized incidence rates of diabetes for Alberta, for selected geographic areas , expressed as per 100,000 population.

SUMMARYThis analysis, designed and executed by Ribble Rivers Trust, identifies areas across England with the greatest levels of diabetes mellitus in persons (aged 17+). Please read the below information to gain a full understanding of what the data shows and how it should be interpreted.ANALYSIS METHODOLOGYThe analysis was carried out using Quality and Outcomes Framework (QOF) data, derived from NHS Digital, relating to diabetes mellitus in persons (aged 17+).This information was recorded at the GP practice level. However, GP catchment areas are not mutually exclusive: they overlap, with some areas covered by 30+ GP practices. Therefore, to increase the clarity and usability of the data, the GP-level statistics were converted into statistics based on Middle Layer Super Output Area (MSOA) census boundaries.The percentage of each MSOA’s population (aged 17+) with diabetes mellitus was estimated. This was achieved by calculating a weighted average based on:The percentage of the MSOA area that was covered by each GP practice’s catchment areaOf the GPs that covered part of that MSOA: the percentage of registered patients that have that illness The estimated percentage of each MSOA’s population with diabetes mellitus was then combined with Office for National Statistics Mid-Year Population Estimates (2019) data for MSOAs, to estimate the number of people in each MSOA with depression, within the relevant age range.Each MSOA was assigned a relative score between 1 and 0 (1 = worst, 0 = best) based on:A) the PERCENTAGE of the population within that MSOA who are estimated to have diabetes mellitusB) the NUMBER of people within that MSOA who are estimated to have diabetes mellitusAn average of scores A & B was taken, and converted to a relative score between 1 and 0 (1= worst, 0 = best). The closer to 1 the score, the greater both the number and percentage of the population in the MSOA that are estimated to have diabetes mellitus, compared to other MSOAs. In other words, those are areas where it’s estimated a large number of people suffer from diabetes mellitus, and where those people make up a large percentage of the population, indicating there is a real issue with diabetes mellitus within the population and the investment of resources to address that issue could have the greatest benefits.LIMITATIONS1. GP data for the financial year 1st April 2018 – 31st March 2019 was used in preference to data for the financial year 1st April 2019 – 31st March 2020, as the onset of the COVID19 pandemic during the latter year could have affected the reporting of medical statistics by GPs. However, for 53 GPs (out of 7670) that did not submit data in 2018/19, data from 2019/20 was used instead. Note also that some GPs (997 out of 7670) did not submit data in either year. This dataset should be viewed in conjunction with the ‘Health and wellbeing statistics (GP-level, England): Missing data and potential outliers’ dataset, to determine areas where data from 2019/20 was used, where one or more GPs did not submit data in either year, or where there were large discrepancies between the 2018/19 and 2019/20 data (differences in statistics that were > mean +/- 1 St.Dev.), which suggests erroneous data in one of those years (it was not feasible for this study to investigate this further), and thus where data should be interpreted with caution. Note also that there are some rural areas (with little or no population) that do not officially fall into any GP catchment area (although this will not affect the results of this analysis if there are no people living in those areas).2. Although all of the obesity/inactivity-related illnesses listed can be caused or exacerbated by inactivity and obesity, it was not possible to distinguish from the data the cause of the illnesses in patients: obesity and inactivity are highly unlikely to be the cause of all cases of each illness. By combining the data with data relating to levels of obesity and inactivity in adults and children (see the ‘Levels of obesity, inactivity and associated illnesses: Summary (England)’ dataset), we can identify where obesity/inactivity could be a contributing factor, and where interventions to reduce obesity and increase activity could be most beneficial for the health of the local population.3. It was not feasible to incorporate ultra-fine-scale geographic distribution of populations that are registered with each GP practice or who live within each MSOA. Populations might be concentrated in certain areas of a GP practice’s catchment area or MSOA and relatively sparse in other areas. Therefore, the dataset should be used to identify general areas where there are high levels of diabetes mellitus, rather than interpreting the boundaries between areas as ‘hard’ boundaries that mark definite divisions between areas with differing levels of diabetes mellitus.TO BE VIEWED IN COMBINATION WITH:This dataset should be viewed alongside the following datasets, which highlight areas of missing data and potential outliers in the data:Health and wellbeing statistics (GP-level, England): Missing data and potential outliersLevels of obesity, inactivity and associated illnesses (England): Missing dataDOWNLOADING THIS DATATo access this data on your desktop GIS, download the ‘Levels of obesity, inactivity and associated illnesses: Summary (England)’ dataset.DATA SOURCESThis dataset was produced using:Quality and Outcomes Framework data: Copyright © 2020, Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital.GP Catchment Outlines. Copyright © 2020, Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital. Data was cleaned by Ribble Rivers Trust before use.COPYRIGHT NOTICEThe reproduction of this data must be accompanied by the following statement:© Ribble Rivers Trust 2021. Analysis carried out using data that is: Copyright © 2020, Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital.CaBA HEALTH & WELLBEING EVIDENCE BASEThis dataset forms part of the wider CaBA Health and Wellbeing Evidence Base.

This dataset present information on age-sex specific incidence rates of diabetes for Alberta and AHS continuum zone, expressed as per 100,000 population.

This dataset is from UCI machine learning repository: 130 US hospital diabetes dataset However, I did several cleaning and this is the output. How I did the cleaning, you can read more here https://github.com/rischanlab/Cleaning_diabetes_130_US_hospital_dataset

The main purpose of creating an electronic database was to evaluate the performance of continuous glucose monitoring (CGM) and flash monitoring (FMS) in children and adolescents diagnosed with type 1 diabetes mellitus. The database is intended for entering, systematizing, storing and displaying patient data (date of birth, age, date of diagnosis of type 1 diabetes mellitus, length of illness, date of first visit to an endocrinologist, with the installation of a CGM or FMS), glycated hemoglobin indicators initially , during the study and ultimately, as well as CGM, FMS data (average glucose level, glycemic variability, percentage of cases above the target range, percentage of cases within the target range, percentage of cases below the target range, number of hypoglycemic episodes and their average duration, frequency of daily scans and frequency of sensor readings).

The database is the basis for comparative statistical analysis of dynamic monitoring indicators in groups of patients with the presence or absence of diabetic complications (neuropathy, retinopathy and nephropathy). The database presents the results of a prospective, open, controlled, clinical study obtained over a year and a half. The database includes information on 307 patients (adolescent children) aged 3 to 17 years inclusive. During the study, the observed patients were divided into two groups: Group 1 - patients diagnosed with type 1 diabetes mellitus and with diabetic complications, 152 people, Group 2 – patients diagnosed with type 1 diabetes mellitus and with no diabetic complications, 155 people. All registrants of the database were assigned individual codes, which made it possible to exclude personal data (full name) from the database.

The database is executed in the Microsoft Office Excel program and has the character of a depersonalized summary table, which consists of two blocks-sheets: patients of groups 1 and 2 and is structured according to the following sections: "Patient number"; "Patient code"; "Date of birth"; "Age of the patient"; section "Date of diagnosis of DM1" indicates the date of the official diagnosis of type 1 diabetes mellitus at the first hospitalization of the patient, this information is borrowed from medical information systems; section "Length of service DM1" reflects information about the duration of the patient's illness; the section "Date of the first visit" contains information about the date of the registrant's visit to the endocrinologist with the installation of FMS / CGM devices; the section "Frequency of self-monitoring with a glucometer" contains information about the frequency of measuring blood glucose levels by the patient at home using a glucometer until the establishment of FMS / CGM.

Sections "HbA1c initially (GMI)", "HbA1c (GMI)", "HbA1c final (GMI)", display the indicators of the level of glycated hemoglobin from the total for the period of the beginning of the study, at the intermediate stages of the study and at the end of observation.

The database structure has a number of sections accumulating information obtained with CGM/FMS, in particular: the section "Average glucose level"; the section "% above the target range", reflecting the percentage of the patient's stay with glycemia above the target indicators during the day; the section "% within the target range", reflecting the percentage of the patient's stay within the target glycemia indicators per day; the section "% below the target range", reflecting the percentage of the patient's stay with glycemia below the target indicators during the day; the section "Hypoglycemic phenomena", reflecting the number of cases of hypoglycemia in patients within 2 weeks; the section "Average duration", reflecting the average duration of hypoglycemic phenomena registered in the patient; the section "Sensor data received", indicating the percentage of time the patient was with an active device sensor; the section "Daily scans" show the frequency of scans of the patient's glycemic level (once a day); the section "%CV" displays the variability of the patient's glycemia recorded by the device. The listed sections are repeated in the database in accordance with the number of follow-up visit.

Also in the database there is a section "Mid. values", which contains indicators of the average values of patient data for all of the above sections, both in the first and in the second group of patients.

When working with the database, the use of filters (in the "Data" tab) containing the names of indicators allows you to enter information about new registrants in a convenient form or correct existing data, as well as sort and search for one or more specified indicators.

The electronic database allows you to systematize a large volume of results, distribute data into categories, search for any field or set of fields in the input format, systematize the selected array, makes it possible to directly use this data for statistical analysis, as well as to view and print information on specified conditions with the location of fields in a convenient sequence.

There are two Excel .csv files containing questions on type 2 diabetes mellitus tagged by the specific topics each question covers. clinicquestions.csv has questions collected from 100 patients. crowdsourcedquestions.csv has questions collected from 300 members of the public. Questions on type 1 diabetes were removed, as were questions on clinic operations. Details on the coding can be found in the citation (below).clinicquestions.csvNumber of instances: 152Number of attributes: 25Attribute characteristics: text; integer IDs, one-hot encodingsMissing data: nonecrowdsourcedquestions.csv Number of instances: 284Number of attributes: 26Attribute characteristics: text; categorical (Female/Male); integer IDs, one-hot encodingsMissing data: noneATTRIBUTES:gender – categorical (Male/Female)person_ID – Integer identifier for the person asking the question qx_ID – Integer identifier for the questionQx – The text of the question itself, as asked, without corrections or edits22 topic categories one-hot encoded:CAUSE ; RISK; PREVENTION; DIAGNOSIS; MANIFESTATIONS; TREATMENT; ANATOMY; CURE; DIET; EXERCISE; WEIGHT; SELF-MANAGEMENT; DISEASE COMPLICATIONS; TREATMENT COMPLICATIONS; PERSON or ORGANIZATION; PROGNOSIS; DISTRIBUTION of a DISEASE in a POPULATION; INHERITANCE PATTERNS; RESEARCH; PSYCHOSOCIAL; Own HEALTH RECORD RELATED; OTHER CITATION:

Crangle CE, Bradley C, Carlin PF, Esterhay RJ, Harper R, Kearney PM, Lorig K, McCarthy VJC, McTear M, Savage E, Tuttle MS, Wallace JG. (2018, to appear) Exploring Patient Information Needs: A Cross Sectional Study of Questions on Type 2 Diabetes. PLOS ONE

Number and percentage of persons having been diagnosed with diabetes, by age group and sex.

heart rate